Glenn Flux

Royal Marsden Hospital
Head of radioisotope physics

Dr Glenn Flux is Head of Radioisotope Physics at the Royal Marsden Hospital and Institute of Cancer Research in Sutton, UK. His main research focus is on translational quantitative SPECT and PET imaging and its application to internal dosimetry for molecular radiotherapy. He has been involved in the development of imaging and dosimetry for clinical procedures including I-131 mIBG treatment of neuroblastoma and the treatment and palliation of bone metastases from prostate cancer with Re-186 HEDP and Ra-223. He has published over 100 peer reviewed articles and received research funding from national and international bodies. He is a founder member of the EANM Dosimetry Committee and is currently chair of the British Nuclear Medicine Society Molecular Radiotherapy committee.

dont miss

The emergence and resurgence of radiotherapeutics for cancer treatment

Cancer treatment with radiopharmaceuticals is growing rapidly with many new radiotherapeutics either in development or early phase trials. Molecular radiotherapy and theragnostics promise to offer significant advances in cancer care and the market is expected to grow by 30% per annum for the foreseeable future. This presentation will review the potential impact of this expansion for industry, academia, and patient benefit.

EVEN MORE SEMINARS

  • Dr Arjun Nair: Speaking at the European Neurological Convention

    Dr Arjun Nair
    The Harley Street Clinic (Part of HCA healthcare UK)

    Advance Technologies in Diagnostics

  • Glenn Flux: Speaking at the European Neurological Convention

    Glenn Flux
    Royal Marsden / Institute of Cancer Research

    The emergence and resurgence of radiotherapeutics for cancer treatment

  • Dr Ben Timmis: Speaking at the European Neurological Convention

    Dr Ben Timmis
    4ways Healthcare Ltd

    How to manage x-ray reporting risk with fewer consultant radiologists

  • Dr Elizabeth Loney: Speaking at the European Neurological Convention

    Dr Elizabeth Loney
    County Durham and Darlington NHS FT

    Chairing session 2:Thyroid and Parathyroid

  • Dr John Buscombe: Speaking at the European Neurological Convention

    Dr John Buscombe
    British Nuclear Medicine Society

    Theranostics in prostate cancer new or false dawn